Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Гастроэзофагеальная рефлюксная болезнь у беременных (лекция для практикующих врачей)
Гастроэзофагеальная рефлюксная болезнь у беременных (лекция для практикующих врачей)
Шарашкина Н.В., Рунихина Н.К. Гастроэзофагеальная рефлюксная болезнь у беременных (лекция для практикующих врачей). Consilium Medicum. 2013; 15 (6): 24–26.
Материалы доступны только для специалистов сферы здравоохранения.
Чтобы посмотреть материал полностью
Авторизуйтесь
или зарегистрируйтесь.
Полный текст
Список литературы
1. Шехтман М.М. Руководство по экстрагенитальной патологии у беременных. М., 2008.
2. Ивашкин В.Т., Шептулин А.А., Трухманов А.С. и др. Рекомендации по обследованию и лечению больных гастроэзофагеальной рефлюксной болезнью. М., 2002.
32. Dent J, Jones R, Kahrilas P, Talley NI. Management of gastro-
oesophageal reflux disease in general practice. BMJ 2001; 322: 344–7.
4. Gill SK, O'Brien L, Einarson TR, Koren G. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol 2009; 104 (6): 1541–5.
5. Gill SK, O’Brien L, Koren G. The safety of histamine 2 (H2) blockers in pregnancy: a meta-analysis. Dig Dis Sci 2009; 54 (9): 1835–8.
6. Larson JD, Patatanian E, Miner PB et al. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynec 1997; 90: 83–7.
7. Lundell L. Advances in treatment strategies for gastroesophageal reflux disease. EAGE Postgraduate Course. Geneva, 2002; р. 13–22.
8. Majithia R, Johnson DA. Are proton pump inhibitors safe during pregnancy and lactation. Drugs 2012; 72 (2): 171–9.
9. Malfertheiner SF, Malfertheiner MV, Kropf S et al A prospective longitudinal cohort study: evolution of GERD symptoms during the course ofpregnancy. BMC Gastroenterol 2012; 12: 131.
10. Naumann CR, Zelig C, Napolitano PG et al. Nausea, vomiting, and heartburn in pregnancy: a prospective look at risk, treatment, and outcome. J Matern Fetal Neonatal Med 2012; 25 (8): 1488–93.
11. Ramu B, Mohan P, Rajasekaran MS, Jayanthi V. Prevalence and risk factors for gastroesophageal reflux in pregnancy. Indian J Gastroenterol 2011; 30 (3): 144–7.
12. Rey E, Rodríguez-Artalejo F, Herraiz MA et al. Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study. Am J Gastroenterol 2007; 102 (11): 2395–400.
13. Rey E, Rodríguez-Artalejo F, Herraiz MA et al. Atypical symptoms of gastro-esophageal reflux during pregnancy. Rev Esp Enferm Dig 2011; 103 (3): 129–32.
14. Rhim AD, Hardy JR, Haynes K et al. Maternal use of proton pump inhibitors during pregnancy is associated with an increased risk for cardiac birth defects: analysis of 208,951 pregnancies from the database (abstr). Gastroenterology 2010; 138: S-63.
15. Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroent Clinics 2003; 32 (1): 235–61.
16. Spechler SJ. Epidemiology of gastro-oesophageal history of gastro-
oesophageal reflux disease. Digestion 1992; 51 (Suppl. 1): 24–9.
17. Stanghellini V. Management of gastroesophageal reflux disease. Drugs Today (Bare) 2003; 39 (Suppl. A): 15–20.
18. Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101 (8): 1900–20.
2. Ивашкин В.Т., Шептулин А.А., Трухманов А.С. и др. Рекомендации по обследованию и лечению больных гастроэзофагеальной рефлюксной болезнью. М., 2002.
32. Dent J, Jones R, Kahrilas P, Talley NI. Management of gastro-
oesophageal reflux disease in general practice. BMJ 2001; 322: 344–7.
4. Gill SK, O'Brien L, Einarson TR, Koren G. The safety of proton pump inhibitors (PPIs) in pregnancy: a meta-analysis. Am J Gastroenterol 2009; 104 (6): 1541–5.
5. Gill SK, O’Brien L, Koren G. The safety of histamine 2 (H2) blockers in pregnancy: a meta-analysis. Dig Dis Sci 2009; 54 (9): 1835–8.
6. Larson JD, Patatanian E, Miner PB et al. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynec 1997; 90: 83–7.
7. Lundell L. Advances in treatment strategies for gastroesophageal reflux disease. EAGE Postgraduate Course. Geneva, 2002; р. 13–22.
8. Majithia R, Johnson DA. Are proton pump inhibitors safe during pregnancy and lactation. Drugs 2012; 72 (2): 171–9.
9. Malfertheiner SF, Malfertheiner MV, Kropf S et al A prospective longitudinal cohort study: evolution of GERD symptoms during the course ofpregnancy. BMC Gastroenterol 2012; 12: 131.
10. Naumann CR, Zelig C, Napolitano PG et al. Nausea, vomiting, and heartburn in pregnancy: a prospective look at risk, treatment, and outcome. J Matern Fetal Neonatal Med 2012; 25 (8): 1488–93.
11. Ramu B, Mohan P, Rajasekaran MS, Jayanthi V. Prevalence and risk factors for gastroesophageal reflux in pregnancy. Indian J Gastroenterol 2011; 30 (3): 144–7.
12. Rey E, Rodríguez-Artalejo F, Herraiz MA et al. Gastroesophageal reflux symptoms during and after pregnancy: a longitudinal study. Am J Gastroenterol 2007; 102 (11): 2395–400.
13. Rey E, Rodríguez-Artalejo F, Herraiz MA et al. Atypical symptoms of gastro-esophageal reflux during pregnancy. Rev Esp Enferm Dig 2011; 103 (3): 129–32.
14. Rhim AD, Hardy JR, Haynes K et al. Maternal use of proton pump inhibitors during pregnancy is associated with an increased risk for cardiac birth defects: analysis of 208,951 pregnancies from the database (abstr). Gastroenterology 2010; 138: S-63.
15. Richter JE. Gastroesophageal reflux disease during pregnancy. Gastroent Clinics 2003; 32 (1): 235–61.
16. Spechler SJ. Epidemiology of gastro-oesophageal history of gastro-
oesophageal reflux disease. Digestion 1992; 51 (Suppl. 1): 24–9.
17. Stanghellini V. Management of gastroesophageal reflux disease. Drugs Today (Bare) 2003; 39 (Suppl. A): 15–20.
18. Vakil N, van Zanten SV, Kahrilas P et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101 (8): 1900–20.
Авторы
Н.В.Шарашкина, Н.К.Рунихина
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава РФ, Москва
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава РФ, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.